Albers Jeffrey W. Insider Trading Activity
Corporate InsiderDirector · CIK 1638474
Performance Scorecard
Forward stock performance after each transaction by Albers Jeffrey W.. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -3.7% | 50% | 6 |
| 90 days | — | +1.0% | 75% | 4 |
| 120 days | — | -8.8% | 50% | 4 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade Markers🔒 Subscribe to see trade entries
Pro members see exactly when Albers Jeffrey W. bought and sold KYMR.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Dec 8, 2025 | KYMR | Sell | 2,748 | $89.32 | $245K | −55.0% | Director | |
Dec 8, 2025 | KYMR | Sell | 2,252 | $90.30 | $203K | −100.0% | Director | |
Oct 13, 2025 | KYMR | Sell | 5,000 | $59.19 | $296K | −100.0% | Director | |
Jun 3, 2025 | KYMR | Sell | 6,349 | $49.00 | $311K | −100.0% | Director | |
May 27, 2025 | BPMC | Sell | 4,350 | $101.02 | $439K | −2.9% | Director | |
May 27, 2025 | BPMC | Sell | 650 | $101.93 | $66K | −0.4% | Director |
Top Companies Traded
Other insiders at Kymera Therapeutics, Inc.
10 other tracked filers at KYMR.
Bruce Booth
Director
53
Trades
Jeremy G Chadwick
COO
29
Trades
Gollob Jared
Chief Medical Officer
18
Trades
Mainolfi Nello
CEO
16
Trades
Esposito Pamela
Director
13
Trades
Jacobs Bruce N.
CFO
8
Trades
Ridloff Elena
Director
7
Trades
Goodman Noah
Chief Business Officer
5
Trades
Baker Bros. Advisors LPInstitutional
Director
4
Trades
Bvf Partners L P/ilInstitutional
Director
3
Trades